{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:28:25Z","timestamp":1761560905986},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.peptides.2004.06.011","type":"journal-article","created":{"date-parts":[[2004,8,4]],"date-time":"2004-08-04T18:11:17Z","timestamp":1091643077000},"page":"1873-1881","source":"Crossref","is-referenced-by-count":19,"title":["Efficacy of human \u03b2-casein fragment (54\u201359) and its synthetic analogue compound 89\/215 against Leishmania donovani in hamsters"],"prefix":"10.1016","volume":"25","author":[{"given":"Preeti","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasib","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravendra","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wahajul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Dube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2004.06.011_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0006-291X(74)90640-8","article-title":"Adjuvant activity of monomeric bacterial cell wall peptidoglycans","volume":"59","author":"Adam","year":"1974","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2004.06.011_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/IAI.48.2.409-416.1985","article-title":"Synergistic effects of glucantime and liposome encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis","volume":"48","author":"Adinolfi","year":"1985","journal-title":"Infect. Immun."},{"key":"10.1016\/j.peptides.2004.06.011_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199001043220104","article-title":"Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma","volume":"322","author":"Badaro","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.peptides.2004.06.011_bib4","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1017\/S0031182000075375","article-title":"Interaction between immunity and chemotherapy in the treatment of trypanosomiasis and leishmaniasis","volume":"105","author":"Berger","year":"1992","journal-title":"Parasitology"},{"key":"10.1016\/j.peptides.2004.06.011_bib5","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.152.12.5949","article-title":"Restoration of IFN-\u03b3 production and lymphocyte proliferation in visceral leishmaniasis","volume":"152","author":"Carvalho","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.peptides.2004.06.011_bib6","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/IAI.33.2.498-500.1981","article-title":"Cell mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection","volume":"33","author":"Carvalho","year":"1981","journal-title":"Infect. Immun."},{"key":"10.1016\/j.peptides.2004.06.011_bib7","first-page":"567","article-title":"Visceral leishmaniasis in mice: protective effect of glucan","volume":"27","author":"Cook","year":"1980","journal-title":"J. Reticuloendothel. Soc."},{"key":"10.1016\/j.peptides.2004.06.011_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0169-4758(91)90079-4","article-title":"The immune dependence of chemotherapy","volume":"7","author":"Doenhoff","year":"1991","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.peptides.2004.06.011_bib9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0006-291X(74)90458-6","article-title":"Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives","volume":"59","author":"Ellouz","year":"1974","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.peptides.2004.06.011_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0035-9203(94)90518-5","article-title":"Clinical healing of antimony resistant cutaneous or mucpcutaneous leishmaniasis following the combined administration of IFN-\u03b3 and pentavalent antimonial compounds","volume":"88","author":"Falcoff","year":"1994","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.peptides.2004.06.011_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4269\/ajtmh.1983.32.286","article-title":"Efficacy of combined immunostimulation and chemotherapy in experimental visceral leishmaniasis","volume":"32","author":"Haidaris","year":"1983","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.peptides.2004.06.011_bib12","first-page":"207","article-title":"Immunosuppression in Kenyan visceral leishmaniasis","volume":"51","author":"Ho","year":"1983","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.peptides.2004.06.011_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0035-9203(91)90155-R","article-title":"Immune-dependence of chemotherapy of experimental visceral leishmaniasis","volume":"85","author":"Iwobi","year":"1991","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"12","key":"10.1016\/j.peptides.2004.06.011_bib14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.tibtech.2003.10.005","article-title":"Therapeutic peptides","volume":"21","author":"Lein","year":"2003","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.peptides.2004.06.011_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0008-8749(77)90288-X","article-title":"Target cells for the activity of a synthetic adjuvant: muramyl dipeptide","volume":"29","author":"Lowy","year":"1977","journal-title":"Cell Immunol."},{"key":"10.1016\/j.peptides.2004.06.011_bib16","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0192-0561(00)00074-6","article-title":"Immunomodulators in infectious diseases: panoply of possibilities","volume":"22","author":"Masihi","year":"2000","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.peptides.2004.06.011_bib17","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","article-title":"The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response","volume":"166","author":"Melby","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.peptides.2004.06.011_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0024-3205(80)90351-3","article-title":"A short lipopeptide, representative of a new family of immunological adjuvants devoid of sugar","volume":"26","author":"Migliore-Samour","year":"1980","journal-title":"Life Sci."},{"key":"10.1016\/j.peptides.2004.06.011_bib19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/infdis\/157.5.973","article-title":"Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony","volume":"157","author":"Murray","year":"1988","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.peptides.2004.06.011_bib20","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1128\/AAC.37.7.1504","article-title":"Treatment of experimental visceral leishmaniasis in a \u2018T\u2019 cell-deficient host: response to amphotericin B and pentamidine","volume":"37","author":"Murray","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.peptides.2004.06.011_bib21","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI114009","article-title":"Requirement of \u2018T\u2019 cells and effect of lymphokines in successful chemotherapy for an intracellular infection","volume":"83","author":"Murray","year":"1989","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.peptides.2004.06.011_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jac\/14.5.463","article-title":"An in vitro system for determining the activity of compounds against the intracellular amastigotes forms of Leishmania donovani","volume":"14","author":"Neal","year":"1984","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.peptides.2004.06.011_bib23","first-page":"579","article-title":"Leishmania donovani in hamster: migration of amastigotes to unusual sites following drug therapy","volume":"17","author":"Pal","year":"1989","journal-title":"Med. Sci. Res."},{"key":"10.1016\/j.peptides.2004.06.011_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/BF01959951","article-title":"Leishmania donovani in hamsters: stimulation of non-specific resistance by some novel glycopeptide and impact on therapeutic efficacy","volume":"47","author":"Pal","year":"1991","journal-title":"Experientia"},{"key":"10.1016\/j.peptides.2004.06.011_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0192-0561(79)90028-6","article-title":"Fate of the synthetic immunoadjuvant muramyl dipeptide (14C labeled) in mouse","volume":"1","author":"Parant","year":"1979","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.peptides.2004.06.011_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1432-1033.1984.tb08609.x","article-title":"Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis and biological properties","volume":"145","author":"Parker","year":"1984","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.peptides.2004.06.011_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/00034983.1988.11812239","article-title":"Effect of levimasloe on the course of experimental leishmaniasis in guinea pigs and mice: haematological and immunological findings","volume":"82","author":"Rezai","year":"1988","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.peptides.2004.06.011_bib28","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4049\/jimmunol.138.3.908","article-title":"An analysis of \u2018T\u2019 cell responsiveness in Indian Kala-azar","volume":"138","author":"Sacks","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.peptides.2004.06.011_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/08923979609052751","article-title":"Synthesis and immunostimulant activity of novel analogs of human casein fragment (54-59)","volume":"18","author":"Sahai","year":"1996","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.peptides.2004.06.011_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/08820139109082624","article-title":"Macrophage migration as an index of immune status","volume":"20","author":"Saxena","year":"1991","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.peptides.2004.06.011_bib31","first-page":"728","article-title":"Synthesis of immunostimulating hexapeptide corresponding to sequence (54-59) of human \u03b2-casein","volume":"30B","author":"Sharan","year":"1991","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.peptides.2004.06.011_bib32","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0196-9781(99)00146-1","article-title":"Stimulation of nonspecific resistance by thymopentin and its analogs against Leishmania donovani infection in hamsters","volume":"20","author":"Sharma","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2004.06.011_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/092986650304220615155913","article-title":"Stimulation of non-specific resistance by human \u03b2-casein fragment (54-59) and its synthetic analogues against Leishmania donovani infection","volume":"3","author":"Sharma","year":"1996","journal-title":"Protein Peptide Lett."},{"key":"10.1016\/j.peptides.2004.06.011_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/IAI.16.1.249-257.1977","article-title":"Effect of treatment with BCG on the course of visceral leishmaniasis in BALB\/c mice","volume":"16","author":"Smrkovski","year":"1977","journal-title":"Infect. Immun."},{"key":"10.1016\/j.peptides.2004.06.011_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S0031182003003457","article-title":"Prophylactic potential of autoclaved Leishmania donovani with BCG against experimrental visceral leishmaniasis","volume":"127","author":"Srivastatava","year":"2003","journal-title":"Parasitology"},{"key":"10.1016\/j.peptides.2004.06.011_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0008-8749(79)90157-6","article-title":"The adjuvant activity of synthetic N-acetyl muramyl dipeptide: evidence of initial target cells for adjuvant activity","volume":"43","author":"Sugimura","year":"1979","journal-title":"Cell Immunol."},{"key":"10.1016\/j.peptides.2004.06.011_bib37","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.peptides.2004.06.011_bib38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF01941270","article-title":"Leishmania donovani in hamsters: stimulation of non-specific resistance by novel lipopeptides and their effect in antileishmanial therapy","volume":"51","author":"Zehra","year":"1995","journal-title":"Experientia"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978104002773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978104002773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T04:05:45Z","timestamp":1682741145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978104002773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0196978104002773"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2004.06.011","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}